Illumina Acquires Fluent BioSciences
July 9, 2024
Illumina, Inc. has acquired Fluent BioSciences to integrate Fluent's PIPseq single-cell technology into Illumina's product portfolio and accelerate its multiomics capabilities. The acquisition, which closed July 9, 2024 and was funded with cash on hand, brings Fluent's accessible, scalable single-cell chemistry and the Fluent team into Illumina to expand end-to-end single-cell solutions for research and applied customers.
- Buyers
- Illumina, Inc.
- Targets
- Fluent BioSciences
- Industry
- Biotechnology
- Location
- Massachusetts, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Illumina Acquires SomaLogic from Standard BioTools
January 30, 2026
Healthcare Services
Illumina, Inc. completed its acquisition of SomaLogic, adding data-driven proteomics technology to expand its multiomics portfolio. The deal was for $350 million in upfront cash at closing, plus up to $75 million in near-term performance-based milestones/royalties, with Illumina expecting to fund the transaction with cash on hand.
-
10x Genomics to Acquire Scale Biosciences
August 7, 2025
Healthcare Services
10x Genomics, Inc. has signed a definitive agreement to acquire Scale Biosciences, Inc., a single-cell analysis company. The deal is intended to expand 10x’s Chromium platform with Scale’s key inventions and technologies and broaden access to scalable single-cell analysis for researchers worldwide.
-
Anaplan Acquires Fluence Technologies
April 26, 2024
Cloud & SaaS
Anaplan has entered into a definitive agreement to acquire Fluence Technologies, a Toronto-based provider of cloud-native financial close, consolidation, disclosure management and Excel reporting software. The acquisition (expected to close in early May) will integrate Fluence’s consolidation and disclosure capabilities into Anaplan’s connected planning platform to strengthen CFO-focused functionality and reduce system and process complexity. Integration will be led by Anaplan’s product leaders alongside Fluence product leadership.
-
Cell Microsystems Acquires Fluxion Biosciences
August 23, 2023
Medical Devices
Durham-based Cell Microsystems has acquired Fluxion Biosciences, adding Fluxion's IonFlux, BioFlux and IsoFlux instruments and services to its CellRaft-based product portfolio. The deal is supported by a concurrent Series B financing led by Telegraph Hill Partners to provide growth capital and accelerate product and service integration for cellular analysis and electrophysiology workflows.
-
Agilent Technologies Acquires Avida Biomed
January 4, 2023
Biotechnology
Agilent Technologies has acquired Avida Biomed, an early-stage developer of high-performance NGS target enrichment workflows for cancer research. The acquisition augments Agilent's SureSelect portfolio and expands its capabilities into high-growth clinical research and diagnostics markets by adding Avida's chemistries and automatable assays compatible with Agilent platforms.
-
Integrated DNA Technologies Acquires Swift Biosciences
March 11, 2021
Biotechnology
Integrated DNA Technologies (IDT) has acquired Swift Biosciences, a developer of Next-Generation Sequencing (NGS) library preparation and enrichment kits. The acquisition brings Swift's library prep and enrichment portfolio and Ann Arbor-based team into IDT to expand IDT's NGS product offerings and accelerate growth in academic, translational, and clinical research markets. Financial terms were not disclosed.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.